The influence of glycosylation on secretion, stability, and immunogenicity of recombinant HBV pre-S antigen synthesized in Saccharomyces cerevisiae.

[1]  Y. Doyon,et al.  Effect of C-domain N-glycosylation and deletion on rat pancreatic alpha-amylase secretion and activity. , 2002, The Biochemical journal.

[2]  B. Wahrén,et al.  Enhanced immunogenicity of a human immunodeficiency virus type 1 env DNA vaccine by manipulating N-glycosylation signals. Effects of elimination of the V3 N306 glycan. , 2001, Vaccine.

[3]  M. Page,et al.  A Novel, Recombinant Triple Antigen Hepatitis B Vaccine (Hepacare®) , 2001, Intervirology.

[4]  S. Rogers,et al.  Cutting Edge: Granzyme B Proteolysis of a Neuronal Glutamate Receptor Generates an Autoantigen and Is Modulated by Glycosylation1 , 2001, The Journal of Immunology.

[5]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[6]  J. Pratap,et al.  Characteristics of glycosylated streptokinase secreted from Pichia pastoris: enhanced resistance of SK to proteolysis by glycosylation , 2000, Applied Microbiology and Biotechnology.

[7]  S. Chatfield,et al.  T-cell and antibody response characterisation of a new recombinant pre-S1, pre-S2 and SHBs antigen-containing hepatitis B vaccine; demonstration of superior anti-SHBs antibody induction in responder mice. , 1999, Vaccine.

[8]  J. Olsen,et al.  Effect of N-Linked Glycosylation on Secretion, Activity, and Stability of α-Amylase from Aspergillus oryzae , 1998, Current Microbiology.

[9]  R. Beavis,et al.  Structural studies of alpha-N-acetylgalactosaminidase: effect of glycosylation on the level of expression, secretion efficiency, and enzyme activity. , 1998, Archives of biochemistry and biophysics.

[10]  B. Seong,et al.  Enhanced secretion of human granulocyte colony-stimulating factor directed by a novel hybrid fusion peptide from recombinant Saccharomyces cerevisiae at high cell concentration. , 1998, Biotechnology and bioengineering.

[11]  R. Baska,et al.  Glycosylation of active human renin is necessary for secretion: effect of targeted modifications of Asn-5 and Asn-75. , 1993, DNA and cell biology.

[12]  C. Scorer,et al.  Foreign gene expression in yeast: a review , 1992, Yeast.

[13]  J. A. Gorman,et al.  Secretion of N-glycosylated interleukin-1 beta in Saccharomyces cerevisiae using a leader peptide from Candida albicans. Effect of N-linked glycosylation on biological activity. , 1991, The Journal of biological chemistry.

[14]  W. Gerlich,et al.  Protective potential of hepatitis B virus antigens other than the S gene protein. , 1990, Vaccine.

[15]  A. Neurath,et al.  Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective. , 1989, Vaccine.

[16]  G. Cesareni,et al.  A novel leader peptide which allows efficient secretion of a fragment of human interleukin 1 beta in Saccharomyces cerevisiae. , 1987, The EMBO journal.

[17]  A. R. Neurath,et al.  Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus , 1986, Cell.

[18]  Hans Wolf,et al.  Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS , 1986, Cell.

[19]  F. Chisari,et al.  Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen. , 1985, Science.

[20]  Jun Sung Jang,et al.  Novel Secretion System of Recombinant Saccharomyces cerevisiae Using an N‐terminus Residue of Human IL‐1β as Secretion Enhancer , 1999, Biotechnology progress.

[21]  W. Gerlich,et al.  Improved immunogenicity in mice of a mammalian cell-derived recombinant hepatitis B vaccine containing pre-S1 and pre-S2 antigens as compared with conventional yeast-derived vaccines. , 1994, Vaccine.

[22]  S. Kent,et al.  The pre-S region of hepadnavirus envelope proteins. , 1988, Advances in virus research.